UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$336M |
| 2 |
AbbVie
ABBV
|
+$235M |
| 3 |
VMW
VMware, Inc
VMW
|
+$163M |
| 4 |
T-Mobile US
TMUS
|
+$156M |
| 5 |
Aptiv
APTV
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$570M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
Apple
AAPL
|
+$394M |
| 4 |
Abbott
ABT
|
+$262M |
| 5 |
Intel
INTC
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Scholastic
SCHL
$792M
| $691K | ﹤0.01% |
23,077
+2,712
| +13% | +$78.1K |
|
1927
Travere Therapeutics
TVTX
$5.78B
| $688K | ﹤0.01% |
33,715
+3,455
| +11% | +$55K |
|
|
DMC
1928
Del Monte Corp
DMC
$1.45B
| $687K | ﹤0.01% |
27,907
-974
| -3% | -$25.5K |
|
1929
Talos Energy
TALO
$2.4B
| $686K | ﹤0.01% |
74,559
+13,936
| +23% | +$145K |
|
1930
Enanta Pharmaceuticals
ENTA
$400M
| $686K | ﹤0.01% |
13,654
-1,161
| -8% | -$60.1K |
|
1931
TTEC Holdings
TTEC
$124M
| $683K | ﹤0.01% |
14,664
-2,161
| -13% | -$86.2K |
|
|
CWEN.A
1932
DELISTED
Clearway Energy Class A
CWEN.A
| $682K | ﹤0.01% |
32,526
-3,800
| -10% | -$74.2K |
|
|
YMAB
1933
DELISTED
Y-mAbs Therapeutics
YMAB
| $680K | ﹤0.01% |
15,749
+7,749
| +97% | +$293K |
|
|
EVOP
1934
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $680K | ﹤0.01% |
29,789
-1,316
| -4% | -$26.2K |
|
|
UCTT
1935
Ultra Clean Holdings
UCTT
$3.95B
| $679K | ﹤0.01% |
30,024
+942
| +3% | +$17.9K |
|
|
NXRT
1936
NexPoint Residential Trust
NXRT
$652M
| $678K | ﹤0.01% |
19,186
-3,003
| -14% | -$92.9K |
|
1937
Designer Brands
DBI
$333M
| $677K | ﹤0.01% |
100,034
+20,359
| +26% | +$123K |
|
1938
Tootsie Roll Industries
TR
$2.98B
| $676K | ﹤0.01% |
23,549
+2,838
| +14% | +$84.2K |
|
|
RDUS
1939
DELISTED
Radius Health, Inc.
RDUS
| $673K | ﹤0.01% |
49,396
+17,743
| +56% | +$244K |
|
|
COOP
1940
DELISTED
Mr. Cooper
COOP
| $666K | ﹤0.01% |
53,574
-3,107
| -5% | -$31.1K |
|
|
PRA
1941
DELISTED
ProAssurance
PRA
| $665K | ﹤0.01% |
45,924
-11,335
| -20% | -$194K |
|
1942
Dine Brands
DIN
$452M
| $664K | ﹤0.01% |
15,766
-751
| -5% | -$30.3K |
|
1943
nLIGHT
LASR
$3.17B
| $664K | ﹤0.01% |
29,817
| – | – |
|
|
MNRL
1944
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $664K | ﹤0.01% |
53,730
+38,092
| +244% | +$462K |
|
1945
Provident Financial Services
PFS
$3.19B
| $664K | ﹤0.01% |
45,918
-20,272
| -31% | -$271K |
|
1946
e.l.f. Beauty
ELF
$5.81B
| $662K | ﹤0.01% |
34,719
+16,297
| +88% | +$233K |
|
1947
Huron Consulting
HURN
$2.42B
| $660K | ﹤0.01% |
14,907
-825
| -5% | -$37.2K |
|
|
AXNX
1948
DELISTED
Axonics, Inc. Common Stock
AXNX
| $659K | ﹤0.01% |
18,774
+10,074
| +116% | +$347K |
|
|
TGI
1949
DELISTED
Triumph Group
TGI
| $659K | ﹤0.01% |
73,156
+26,265
| +56% | +$194K |
|
|
AIMT
1950
DELISTED
Aimmune Therapeutics
AIMT
| $658K | ﹤0.01% |
39,406
+630
| +2% | +$10.7K |
|
Similar funds
UBS AM's Q2 2020 Portfolio in Review
As of Q2 2020, UBS AM held 2,605 positions worth $164B, up 18% from $139B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
UBS AM withdrew a net $6.16B in Q2 2020, closing 142 positions and reducing 1,290 holdings. Its most notable exit was Allergan plc, an estimated $203M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Otis Worldwide worth $76.5M.
- UBS AM's largest Q2 2020 buy was Otis Worldwide: 1,345,382 shares worth $76.5M.
- UBS AM added most to NetEase in Q2 2020, an estimated $336M increase.
- UBS AM's biggest Q2 2020 reduction was Alibaba, cutting an estimated $570M.
- UBS AM fully exited Allergan plc in Q2 2020, selling an estimated $203M.
- UBS AM's ten largest holdings make up 24% of its $164B portfolio in Q2 2020.
- UBS AM opened 144 new positions and closed 142 in Q2 2020.
- UBS AM's portfolio value rose 18% quarter-over-quarter to $164B.
Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.